Mozambique vs Switzerland: Share of S. aureus infections resistant to methicillin
Mozambique
6.7%
in 2022
Switzerland
4.1%
in 2022
Mozambique rank
36th
Switzerland rank
39th
Share of S. aureus infections resistant to methicillin over time
- Mozambique
- Switzerland
How they compare
Mozambique currently reports 6.7% against 4.1% in Switzerland, a difference of 2.6%.
That makes Mozambique's figure about 1.6 times Switzerland's.
The two have swapped places 2 times across 5 shared years of data; in 2018 it was Mozambique ahead.
Mozambique ranks 36th and Switzerland ranks 39th of 45 countries.
Mozambique has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mozambique | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 15.2% | 4.9% | 10.3% | Mozambique |
| 2020s | 18.9% | 11.1% | 7.8% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Mozambique or Switzerland?
- Mozambique, at 6.7% against 4.1% in Switzerland as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Mozambique and Switzerland?
- 2.6%, with Mozambique ahead.
- How many years of comparable data are there for Mozambique and Switzerland?
- 5 years are reported by both, from 2018 to 2022.
- How do Mozambique and Switzerland rank globally for share of s. aureus infections resistant to methicillin?
- Mozambique ranks 36th and Switzerland ranks 39th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).